🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In an open-label parallel groups blinded-endpoint randomized clinical trial...
Status
Terminated
Location
Rajaie Cardiovascular Medical and Research Center
Start Date
2018-12-22
Trial ID
NCT05172115
1. INTRODUCTION Through last couple of years the number of patients tre...
Status
Completed
Location
Albert Einstein College of Medicine
Start Date
2005-01
Trial ID
NCT01863134
Treatments Being Tested
The purpose of this study is to find out if treating multiple myeloma (MM) ...
Status
Completed
Location
University of Arkansas for Medical Sciences
Start Date
2003-12
Trial ID
NCT00113932
Treatments Being Tested
Coagulopathy of COVID-19 afflicts approximately 20% of patients with severe...
Status
Completed
Location
St. Michael's Hospital
Start Date
2020-05-11
Trial ID
NCT04362085
Treatments Being Tested
Anticoagulant therapy is indicated during pregnancy for the prevention and ...
Status
Withdrawn
Location
sahar M.Y elbaradie
Start Date
2017-01
Trial ID
NCT04110444
Treatments Being Tested
The purpose of the study is to evaluate the efficacy and safety of SHR-2004...
Status
Completed
Location
Fourth Medical Center of Chinese People's Liberation Army General Hospital
Start Date
2025-03-16
Trial ID
NCT06825416
This study aims first to assess the efficacy, safety, and effectiveness of ...
Status
Unknown
Location
SZUMC
Start Date
2020-03-28
Trial ID
NCT05925140
Coronavirus disease 2019 (COVID-19), a viral respiratory illness caused by ...
Status
Completed
Location
Henri Mondor Hospital
Start Date
2021-04-14
Trial ID
NCT04808882
Coagulopathy of COVID-19 afflicts approximately 20% of patients with severe...
Status
Completed
Location
Hospital das Clínicas da FMUSP
Start Date
2020-07-04
Trial ID
NCT04444700
Treatments Being Tested
To determine the comparative efficacy and safety of two different doses (75...
Status
Completed
Location
1160.24.01074 Capstone Clinical Trials, Inc.
Start Date
2004-11
Trial ID
NCT00152971